MedTrace Logo

Abdominal Wall Transplant

NCT03310905 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 5

Last updated 2026-01-07

No results posted yet for this study

Summary

The purpose of this protocol is to determine the safety and efficacy of abdominal wall transplantation as a treatment for the reconstruction of abdominal wall defects. Abdominal wall transplantation may be performed alone or in combination with another transplant.

Conditions

  • Transplant;Failure,Kidney
  • Transplant; Failure, Liver
  • Transplant; Failure, Bowel
  • Abdominal Wall Defect
  • Abdominal Wall Fistula
  • Abdominal Wall Hernia
  • Abdominal Wall Injury

Interventions

PROCEDURE

Abdominal Wall Transplant with another solid organ transplant

Transplant of abdominal wall in combination with another solid organ transplant.

PROCEDURE

Abdominal Wall Transplant alone

Abdominal Wall Transplant alone

Sponsors & Collaborators

  • Linda Cendales, MD

    collaborator UNKNOWN

  • Kadiyala Ravindra, M.D.

    collaborator UNKNOWN

  • Detlev Erdmann, M.D.

    collaborator UNKNOWN

  • Duke University

    lead OTHER

Principal Investigators

  • Kadiyala Ravindra, MD · Duke University

  • Linda Cendales, MD · Duke University

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-05-01
Primary Completion
2028-01-01
Completion
2028-06-01

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03310905 on ClinicalTrials.gov